Antibe Therapeutics Collaborates With Dalriada Drug Discovery to Accelerate Pipeline Expansion
- Enables rapid advancement of multiple drug discovery programs to exploit hydrogen sulfide platform in new disease areas TORONTO--(BUSINESS WIRE)--#collaboration--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its